Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease

被引:132
|
作者
Orozco-Levi, M
Gea, J
Lloreta, JL
Félez, M
Minguella, J
Serrano, S
Broquetas, JM
机构
[1] Hosp Mar, IMIM, Serv Pneumol, E-08003 Barcelona, Catalonia, Spain
[2] Hosp Mar, IMIM, Serv Patol, Barcelona, Catalonia, Spain
[3] Hosp Mar, IMIM, Serv Cirurgia Torac, Barcelona, Catalonia, Spain
[4] Hosp Mar, IMIM, Unitat Recerce Resp & Ambiental, Barcelona, Catalonia, Spain
[5] Univ Pompeu Fabra, Barcelona, Catalonia, Spain
[6] Univ Autonoma Barcelona, E-08193 Barcelona, Catalonia, Spain
关键词
chronic obstructive pulmonary disease hyperinflation; mitochondria; respiratory muscles; sarcomeres;
D O I
10.1183/09031936.99.13237199
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pulmonary hyperinflation impairs the function of the diaphragm in patients with chronic obstructive pulmonary disease (COPD). However, it has been recently demonstrated that the muscle can counterbalance this deleterious effect, remodelling its structure (i.e. changing the proportion of different types of fibres). The aim of this study was to investigate whether the functional impairment present in COPD patients can be associated with structural subcellular changes of the diaphragm. Twenty individuals (60+/-9 yrs, 11 COPD patients and 9 subjects with normal spirometry) undergoing thoracotomy were included. Nutritional status and respiratory function were evaluated prior to surgery. Then, small samples of the costal diaphragm were obtained and processed for electron microscopy analysis. COPD patients showed a mean forced expiratory volume in one second (FEV1) of 60+/-9% predicted, a higher concentration of mitochondria (n(mit)) in their diaphragm than controls (0.62+/-0.16 versus 0.46+/-0.16 mitochondrial transections (mt) .mu m(-2), p< 0.05). On the other hand, subjects with air trapping (residual volume (RV)/total lung capacity (TLC) >37%) disclosed not only a higher n(mit) (0.63+/-0.17 versus 0.43+/-0.07 mt.mu m(-2), p<0.05) but shorter sarcomeres (L-sar) than subjects without this functional abnormality (2.08+/-0.16 to 2.27+/-0.15 mu m, p<0.05). Glycogen stores were similar in COPD and controls. The severity of airways obstruction (i.e. FEV1) was associated with n(mit) (r=-0.555, p=0.01), while the amount of air trapping (i.e. RV/TLC) was found to correlate with both n(mit) (r=0.631, p=0.005) and L-sar (r=-0.526, p<0.05). Finally, maximal inspiratory pressure (Pl,mas) inversely correlated with n(mit) (r=-0.547, p=0.01). In conclusion, impairment in lung function occurring in patients with chronic obstructive pulmonary disease is associated with subcellular changes in their diaphragm, namely a shortening in the length of sarcomeres and an increase in the concentration of mitochondria. These changes form a part of muscle remodelling, probably contributing to a better functional muscle behaviour.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 50 条
  • [31] Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment
    Langer, Daniel
    Ciavaglia, Casey E.
    Neder, J. Alberto
    Webb, Katherine A.
    O'Donnell, Denis E.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (06) : 731 - 749
  • [32] Mitochondrial dysfunction in airways and quadriceps muscle of patients with chronic obstructive pulmonary disease
    Haji, Gulam
    Wiegman, Coen H.
    Michaeloudes, Charalambos
    Patel, Mehul S.
    Curtis, Katrina
    Bhavsar, Pankaj
    Polkey, Michael I.
    Adcock, Ian M.
    Chung, Kian Fan
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [33] Inspiratory muscle training in adults with chronic obstructive pulmonary disease: A systematic review
    Geddes, EL
    Reid, WD
    Crowe, J
    O'Brien, K
    Brooks, D
    RESPIRATORY MEDICINE, 2005, 99 (11) : 1440 - 1458
  • [34] Mitochondrial dysfunction in airways and quadriceps muscle of patients with chronic obstructive pulmonary disease
    Gulam Haji
    Coen H. Wiegman
    Charalambos Michaeloudes
    Mehul S. Patel
    Katrina Curtis
    Pankaj Bhavsar
    Michael I. Polkey
    Ian M. Adcock
    Kian Fan Chung
    Respiratory Research, 21
  • [35] Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now?
    Nam, Hae-Seong
    Iunnchenkoi, Evgeny
    Dasgupta, Santanu
    Hoque, Mohammad O.
    BIOMARKERS IN MEDICINE, 2017, 11 (06) : 475 - 489
  • [36] The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients
    Clini, E
    Sturani, C
    Rossi, A
    Viaggi, S
    Corrado, A
    Donner, CF
    Ambrosino, N
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (03) : 529 - 538
  • [37] Targeting cellular senescence as a new approach to chronic obstructive pulmonary disease therapy
    Barnes, Peter J.
    CURRENT OPINION IN PHARMACOLOGY, 2021, 56 : 68 - 73
  • [38] A Prospective Multicentric Study of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease and Different Clinical Phenotypes
    Ambrosino, Nicolino
    Venturelli, Elena
    de Blasio, Francesco
    Paggiaro, Pierluigi
    Pasqua, Franco
    Vitacca, Michele
    Vagheggini, Guido
    Clini, Enrico M.
    RESPIRATION, 2015, 89 (02) : 141 - 147
  • [39] Respiratory muscle power output in patients with chronic heart failure and patients with chronic pulmonary obstructive disease
    Mangelsdorff, G
    Borzone, G
    Leiva, A
    Martínez, A
    Lisboa, C
    REVISTA MEDICA DE CHILE, 2001, 129 (01) : 51 - 59
  • [40] Cyclophilin D Contributes to Airway Epithelial Mitochondrial Damage in Chronic Obstructive Pulmonary Disease
    Zhang, Rui
    Shan, Hu
    Li, Yuer
    Ma, Yuefeng
    Liu, Shiyuan
    Liu, Xiaohuan
    Yang, Xia
    Zhang, Jie
    Zhang, Ming
    LUNG, 2023, 201 (03) : 287 - 295